This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
MorphoSys Bilan de santé
Santé financière contrôle des critères 2/6
MorphoSys has a total shareholder equity of €-261.7M and total debt of €1.7B, which brings its debt-to-equity ratio to -658%. Its total assets and total liabilities are €1.8B and €2.1B respectively.
Informations clés
-658.0%
Ratio d'endettement
€1.72b
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | €630.77m |
| Fonds propres | -€261.67m |
| Total du passif | €2.09b |
| Total des actifs | €1.83b |
Mises à jour récentes de la santé financière
Recent updates
Analyse de la situation financière
Passif à court terme: MOR has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Passif à long terme: MOR has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historique et analyse du ratio d'endettement
Niveau d'endettement: MOR has negative shareholder equity, which is a more serious situation than a high debt level.
Réduire la dette: MOR's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: MOR has sufficient cash runway for more than a year based on its current free cash flow.
Prévisions de trésorerie: MOR has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 35.7% each year